[go: up one dir, main page]

DK1730315T3 - Polymorphismer i NOD2/Card15 gen - Google Patents

Polymorphismer i NOD2/Card15 gen

Info

Publication number
DK1730315T3
DK1730315T3 DK05736111.5T DK05736111T DK1730315T3 DK 1730315 T3 DK1730315 T3 DK 1730315T3 DK 05736111 T DK05736111 T DK 05736111T DK 1730315 T3 DK1730315 T3 DK 1730315T3
Authority
DK
Denmark
Prior art keywords
nod2
polymorphisms
card15
gen
methods
Prior art date
Application number
DK05736111.5T
Other languages
English (en)
Inventor
Hanns-Georg Klein
Original Assignee
Klein Hanss Georg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klein Hanss Georg filed Critical Klein Hanss Georg
Application granted granted Critical
Publication of DK1730315T3 publication Critical patent/DK1730315T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Soy Sauces And Products Related Thereto (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DK05736111.5T 2004-03-27 2005-03-29 Polymorphismer i NOD2/Card15 gen DK1730315T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004015143 2004-03-27
PCT/DE2005/000550 WO2005095640A1 (de) 2004-03-27 2005-03-29 Polymorphismen im nod2/card15 gen

Publications (1)

Publication Number Publication Date
DK1730315T3 true DK1730315T3 (da) 2010-03-08

Family

ID=34965877

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05736111.5T DK1730315T3 (da) 2004-03-27 2005-03-29 Polymorphismer i NOD2/Card15 gen

Country Status (9)

Country Link
US (1) US7803535B2 (da)
EP (1) EP1730315B1 (da)
AT (1) ATE446385T1 (da)
DE (2) DE112005001317A5 (da)
DK (1) DK1730315T3 (da)
ES (1) ES2336581T3 (da)
PL (1) PL1730315T3 (da)
SI (1) SI1730315T1 (da)
WO (1) WO2005095640A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11268149B2 (en) 2004-12-08 2022-03-08 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease
US12110555B2 (en) 2004-12-08 2024-10-08 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease
WO2008109782A2 (en) * 2007-03-06 2008-09-12 Cedars-Sinai Medical Center Diagnosis of inflammatory bowel disease in children
US10544459B2 (en) 2004-12-08 2020-01-28 Cedars-Sinai Medical Center Methods of using genetic variants for the diagnosis and treatment of inflammatory bowel disease
US8703652B2 (en) 2009-11-06 2014-04-22 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive diagnosis of graft rejection in organ transplant patients
US9540443B2 (en) 2011-01-26 2017-01-10 Kolltan Pharmaceuticals, Inc. Anti-kit antibodies
TWI596113B (zh) 2012-07-25 2017-08-21 塞爾德克斯醫療公司 抗kit抗體及其用途
KR101530535B1 (ko) * 2013-06-13 2015-06-23 주식회사 마크로젠 이식편대숙주병 발병 위험성의 예측 방법, 예측용 조성물 및 키트
JP6768639B2 (ja) 2014-05-23 2020-10-21 セルデックス セラピューティクス,インコーポレーテッド 好酸球又はマスト細胞関連障害の治療
KR101541139B1 (ko) 2015-02-13 2015-08-07 주식회사 마크로젠 이식편대숙주병 발병 위험성의 예측 방법, 예측용 조성물 및 키트
KR101541141B1 (ko) 2015-06-25 2015-08-07 주식회사 마크로젠 이식편대숙주병 발병 위험성의 예측 방법, 예측용 조성물 및 키트
KR101593090B1 (ko) * 2015-06-25 2016-02-12 주식회사 마크로젠 이식편대숙주병 발병 위험성의 예측 방법, 예측용 조성물 및 키트
KR101541142B1 (ko) 2015-06-25 2015-08-07 주식회사 마크로젠 이식편대숙주병 발병 위험성의 예측 방법, 예측용 조성물 및 키트
KR101541140B1 (ko) 2015-06-25 2015-08-07 주식회사 마크로젠 이식편대숙주병 발병 위험성의 예측 방법, 예측용 조성물 및 키트

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002243415B2 (en) 2000-10-30 2007-05-24 Regents Of The University Of Michigan Nod2 nucleic acids and proteins
US7205107B2 (en) 2001-12-21 2007-04-17 Cytokine Pharmasciences, Inc. Macrophage migration inhibitory factor (MIF) promoter polymorphism in inflammatory disease
US20040053263A1 (en) * 2002-08-30 2004-03-18 Abreu Maria T. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease

Also Published As

Publication number Publication date
SI1730315T1 (sl) 2010-02-26
ES2336581T3 (es) 2010-04-14
DE502005008373D1 (de) 2009-12-03
EP1730315B1 (de) 2009-10-21
EP1730315A1 (de) 2006-12-13
US7803535B2 (en) 2010-09-28
WO2005095640B1 (de) 2006-03-09
US20070212694A1 (en) 2007-09-13
PL1730315T3 (pl) 2010-03-31
ATE446385T1 (de) 2009-11-15
WO2005095640A1 (de) 2005-10-13
DE112005001317A5 (de) 2007-05-24

Similar Documents

Publication Publication Date Title
WO2004066941A3 (en) Expression profiles for colon cancer and methods of use
PT1597391E (pt) Utilização de arn intrónico para medir a expressão genética
WO2005059108A3 (en) Gene expression profiles and methods of use
DK1730315T3 (da) Polymorphismer i NOD2/Card15 gen
WO2008146309A3 (en) Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
WO2006089233A3 (en) Methods and systems for diagnosis, prognosis and selection of treatment of leukemia
WO2010018601A3 (en) Genetic variants predictive of cancer risk
SG142154A1 (en) Methods for genomic analysis
WO2009059318A3 (en) Genes and polymorphisms associated with amd
NO20084488L (no) Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith
WO2005032495A8 (en) Gene expression profiles and methods of use
TW200636075A (en) Detection of nucleic acid variation by cleavage-amplification method
WO2004078035A3 (en) Expression profiles for breast cancer and methods of use
ATE513929T1 (de) Gene mit einfluss auf die menschliche gedächtnisleistung
WO2006037462A3 (en) Cancer markers
Gu et al. Serum micro RNA s as potential biomarkers of mandibular prognathism
WO2007058968A3 (en) Gene expression profiles and methods of use
MX2009004382A (es) Variaciones geneticas asociadas con tumores.
EP3572530A3 (en) Compositions and methods for detecting mutations in jak2 nucleic acid
WO2008048902A8 (en) Methods of using single nucleotide polymorphisms in the il23r gene to predict or diagnose inflammatory bowel disease
WO2010014905A3 (en) Polymorphisms in the xbp-1 gene associated with inflammatory bowel disease
DK1664102T3 (da) Isoleret photoprotein mtclytin, samt dets anvendelse
NZ576349A (en) Equine performance test
SE0402832D0 (sv) Methods
WO2008070160A3 (en) Cancer-linked genes as biomarkers to monitor response to impdh inhibitors